highly significantP < 0.001
Moreover, silymarin (group V) pretreatment produced highly significant decrease ( P < 0.001) in serum SGOT, SGPT, GGT, ALP total bilirubin, and LDH.
Moreover, silymarin (group V) pretreatment produced highly significant decrease ( P < 0.001) in serum SGOT, SGPT, GGT, ALP total bilirubin, and LDH.